EUVIMEDSkopri EUVIMED
Netzwerk-MetaanalyseSystematische ÜbersichtOpen access · CC BY-NC-ND 4.0

Multimodal treatment improves survival in patients with lung metastases from colorectal cancer: A network meta‐analysis

Andrea Chierici iD, Danilo Vinci iD, Guido Liddo, Stefano Granieri, Mauro Loi, Marco Alifano, Antonio Iannelli

Colorectal Disease · 2025-01 · 27 (1)

DOI: 10.1111/codi.70002 ↗

At a glance

Netzwerk-Metaanalyse in Colorectal Disease, published online on 2025-01-22. Written by Andrea Chierici and 6 co-authors. Institution: Digestive Surgery and Liver Transplantation Unit, Archet 2 Hospital, Centre Hospitalier Universitaire de Nice, Nice, France. Major MEDLINE topics: Colorectal Neoplasms, Lung Neoplasms. Cited 7 times so far (Crossref); 38 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Aim

The lungs represent the second most common site of colorectal cancer metastases. Although surgery is commonly considered the best treatment, many other invasive and noninvasive procedures and treatments have been adopted to improve patient survival and there is no clear evidence in the literature of which is the more effective. The aim of this work was to identify which treatment confers the best gain in overall survival for patients with pulmonary metastases from colorectal cancer.

Method

A systematic review and network meta‐analysis of survival hazard ratio (HR) including 11 studies was conducted following the PRISMA guidelines and the Cochrane protocol on PubMed, Scopus, Embase, Web of Science and Cochrane Library up to 31 December 2023. Surgery, image‐guided thermoablation, stereotactic body radiotherapy, chemotherapy and best standard care, associated or alone, were evaluated. Chemotherapy was adopted as the treatment reference to define survival HRs. Network metaregression was then performed considering patients with pulmonary only or multisite metastases from colorectal cancer.

Results

In patients with pulmonary metastases, the association of surgery, stereotactic body radiotherapy and chemotherapy is the best performing (HR 0.22), while the most effective components alone are image‐guided thermoablation (HR 0.53) and surgery (HR 0.57), although this was not significant. After metaregression, multimodal treatments still represent the strategy conferring the best survival gain. However, while surgery (incremental HR 0.26) has the most important role in patients with isolated pulmonary metastatic disease, chemotherapy (incremental HR 0.3) leads for patients with multimetastatic disease.

Conclusion

Multimodal treatment confers the best gain in overall survival in patients with pulmonary metastases from colorectal cancer. Combining multiple therapeutic strategies improves survival, with oligometastatic patients benefiting more from surgery and local therapies while multimetastatic patients mainly benefit from chemotherapy, although ablation and surgery can enhance outcomes when feasible.

Subjects

MeSH terms (MEDLINE)

Colorectal NeoplasmsLung NeoplasmsAgedFemaleHumansMaleMiddle AgedCombined Modality TherapyRadiosurgerySurvival AnalysisTreatment Outcome

Author keywords

chemotherapycolorectal cancerimaging‐guided thermoablationmeta‐analysispulmonary metastasesradiotherapysurgerysurvival

Authors and institutions

  • Digestive Surgery and Liver Transplantation Unit, Archet 2 Hospital, Centre Hospitalier Universitaire de Nice, Nice, France.
  • General Surgery Department, Ospedale di Vimercate, ASST Della Brianza, Vimercate, Italy.
  • Radiotherapy Department Azienda Universitaria Ospedaliera Careggi, Università Degli Studi di Firenze, Florence, Italy.
  • Thoracic Surgery Department, Cochin Hospital, APHP Centre, University of Paris, Paris, France.
  • Inserm, U1138, Team «Cancer, Immune Control, and Escape», Cordeliers Research Center, University of Paris, Paris, France.
  • Université Côte d'Azur, Nice, France.

ORCID profiles: Andrea Chierici, Danilo Vinci

Cite

APA

Chierici, A., Vinci, D., Liddo, G., Granieri, S., Loi, M., Alifano, M., & Iannelli, A. (2025). Multimodal treatment improves survival in patients with lung metastases from colorectal cancer: A network meta‐analysis. Colorectal Disease, 27(1). https://doi.org/10.1111/codi.70002

Vancouver

Chierici A, Vinci D, Liddo G, Granieri S, Loi M, Alifano M, et al. Multimodal treatment improves survival in patients with lung metastases from colorectal cancer: A network meta‐analysis. Colorectal Disease. 2025;27(1). doi:10.1111/codi.70002

BibTeX
@article{Chierici2025,
  author = {Chierici, Andrea and Vinci, Danilo and Liddo, Guido and Granieri, Stefano and Loi, Mauro and Alifano, Marco and Iannelli, Antonio},
  title = {Multimodal treatment improves survival in patients with lung metastases from colorectal cancer: A network meta‐analysis},
  journal = {Colorectal Disease},
  year = {2025},
  volume = {27},
  number = {1},
  doi = {10.1111/codi.70002}
}
Start for free →